Association of serum and vitreous concentrations of osteoprotegerin with diabetic retinopathy
Authors:
Open Access
- 10 April 2014
- journal article
- research article
- Published by SAGE Publications in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Vol. 52 (2) , 232-236
Abstract
Background: Angiogenesis is involved in the pathogenesis of diabetic retinopathy. Osteoprotegerin, a recently identified glycoprotein belonging to the tumour necrosis factor receptor superfamily, has been implicated to be correlated with angiogenesis. This study aims to determine whether serum and vitreous concentrations of osteoprotegerin are associated with diabetic retinopathy. Methods: This study consisted of 254 diabetic patients (100 without diabetic retinopathy, 64 with non-proliferative diabetic retinopathy and 90 with proliferative diabetic retinopathy) and 62 control subjects. Serum and vitreous concentrations of osteoprotegerin were evaluated using enzyme-linked immunosorbent assay method. Results: Serum and vitreous osteoprotegerin concentrations in proliferative diabetic retinopathy patients were significantly elevated compared with those of the other three groups. Non-proliferative diabetic retinopathy patients showed elevated concentrations of serum and vitreous osteoprotegerin compared with patients without diabetic retinopathy. In addition, control subjects had significantly lower serum and vitreous osteoprotegerin concentrations compared with diabetic patients without retinopathy, non-proliferative diabetic retinopathy patients and proliferative diabetic retinopathy patients. Conclusions: Serum and vitreous osteoprotegerin concentrations are associated with the presence and severity of diabetic retinopathy.Keywords
This publication has 22 references indexed in Scilit:
- SNP rs2073618 of the Osteoprotegerin Gene Is Associated with Diabetic Retinopathy in Slovenian Patients with Type 2 DiabetesBioMed Research International, 2013
- Osteoprotegerin, a new actor in vasculogenesis, stimulates endothelial colony‐forming cells propertiesJournal of Thrombosis and Haemostasis, 2011
- Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitusCardiovascular Diabetology, 2011
- Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patientsDiabetic Medicine, 2010
- Association between plasma osteoprotegerin concentrations and urinary albumin excretion in Type 2 diabetesDiabetic Medicine, 2009
- Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell functionAngiogenesis, 2008
- An Increased Osteoprotegerin Serum Release Characterizes the Early Onset of Diabetes Mellitus and May Contribute to Endothelial Cell DysfunctionThe American Journal of Pathology, 2006
- The Relationship Between Plasma Osteoprotegerin and Endothelium-Dependent Arterial Dilation in Type 2 DiabetesDiabetes, 2006
- An overview of the eye in diabetesJournal of the Royal Society of Medicine, 2003
- The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone ResorptionJournal of Bone and Mineral Research, 2000